Novartis, sees profit, sales drop amid restructuring

February 1, 2023

Novartis and Microsoft join forces to develop drugs using AI

Swiss drug major Novartis has seen its net income decline by 991 per cent to $1.47 billion in the fourth quarter, compared to $16.31 billion in 2022. The company reported on Wednesday. Earnings per share stood at $0.69, down from $7.29 a year ago. The profit drop reflects the absence of inc

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```